| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |